Credit Suisse’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-19,169
Closed -$24K 4674
2020
Q4
$24K Buy
+19,169
New +$22.9K ﹤0.01% 4298
2019
Q4
Sell
-12,398
Closed -$17K 4397
2019
Q3
$17K Buy
12,398
+727
+6% +$1.03K ﹤0.01% 4091
2019
Q2
$17K Sell
11,671
-864
-7% -$1.34K ﹤0.01% 4051
2019
Q1
$19K Buy
+12,535
New +$19.1K ﹤0.01% 3942
2018
Q3
Sell
-14,054
Closed -$26K 4068
2018
Q2
$26K Buy
+14,054
New +$26.2K ﹤0.01% 3930
2015
Q3
Sell
-64,777
Closed -$128K 4559
2015
Q2
$128K Buy
+64,777
New +$184K ﹤0.01% 4346
2015
Q1
Sell
-19,013
Closed -$69K 4643
2014
Q4
$69K Buy
+19,013
New +$50.3K ﹤0.01% 4494

Other funds holding MBII

Credit Suisse's MBII Position: Q1 2021 in Review

Credit Suisse sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2021, closing a stake of 19,169 shares — an estimated $24K sold.

Credit Suisse first reported a position in MBII in Q4 2014 and held it in 7 quarters. The position peaked at $128K in Q2 2015. 74 funds tracked by Wall St. Rank hold MBII as of Q1 2021.

  • Credit Suisse reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2021 after selling out during the quarter.
  • Credit Suisse sold 19,169 Marrone Bio Innovations, Inc. shares in Q1 2021, an estimated $24K.
  • Credit Suisse first reported a position in Marrone Bio Innovations, Inc. in Q4 2014 and held it in 7 quarters.
  • Credit Suisse's Marrone Bio Innovations, Inc. position peaked at $128K in Q2 2015.
  • 74 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.